标题
Repurposing approved drugs for cancer therapy
作者
关键词
-
出版物
BRITISH MEDICAL BULLETIN
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-12-22
DOI
10.1093/bmb/ldaa045
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials
- (2020) M. Chalabi et al. ANNALS OF ONCOLOGY
- TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects
- (2020) Gary J. Haderski et al. PLoS One
- Repurposing drugs in oncology: From candidate selection to clinical adoption
- (2020) Pan Pantziarka et al. SEMINARS IN CANCER BIOLOGY
- Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib
- (2020) Hanping Wang et al. Thoracic Cancer
- Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
- (2020) Min Ae Cho et al. Cancer Research and Treatment
- The Unfolded Protein Response: A Novel Therapeutic Target in Acute Leukemias
- (2020) Alberto M. Martelli et al. Cancers
- Complete Response to Temozolomide in Metastatic Melanoma After Failure of 5 Lines of Treatment
- (2020) Tara Magge et al. AMERICAN JOURNAL OF THERAPEUTICS
- Interferon therapy in myelofibrosis - a systematic review and meta-analysis
- (2020) Jan Philipp Bewersdorf et al. Clinical Lymphoma Myeloma & Leukemia
- Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children’s Oncology Group
- (2020) Kelly D. Getz et al. JOURNAL OF CLINICAL ONCOLOGY
- Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2-positive breast cancer (TRAIN-2): A randomized phase III trial.
- (2020) Anna van der Voort et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulating the Distant Spreading of Patient-Derived Colorectal Cancer Cells via Aspirin and Metformin
- (2020) Gemma Palazzolo et al. Translational Oncology
- Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events
- (2020) Amy Kunchok et al. JAMA Neurology
- Chromosomal instability upregulates interferon in acute myeloid leukemia
- (2020) Ning Jin et al. GENES CHROMOSOMES & CANCER
- A Phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha 2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia not achieving a deep molecular response (MR 4.5) – AGMT_CML 1
- (2020) Sonja Heibl et al. HEMATOLOGICAL ONCOLOGY
- Effect of aspirin on cancer incidence and mortality in older adults
- (2020) John J McNeil et al. JNCI-Journal of the National Cancer Institute
- A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status
- (2020) Dania Vázquez-Blomquist et al. MOLECULAR BIOLOGY REPORTS
- Towards a cancer mission in Horizon Europe: recommendations
- (2020) Anton Berns et al. Molecular Oncology
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study
- (2020) Marie Selvy et al. Journal of Clinical Medicine
- Heme-Dependent ER Stress Apoptosis: A Mechanism for the Selective Toxicity of the Dihydroartemisinin, NSC735847, in Colorectal Cancer Cells
- (2020) Ahmed E. M. Elhassanny et al. Frontiers in Oncology
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Management of Patients with Acute Coronary Syndrome and Cancer
- (2020) Tyler B. Moran et al. Current Cardiology Reports
- NCS 613, a Potent PDE4 Inhibitor, Displays Anti-Inflammatory and Anti-Proliferative Properties on A549 Lung Epithelial Cells and Human Lung Adenocarcinoma Explants
- (2020) Issaka Yougbare et al. Frontiers in Pharmacology
- Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition
- (2019) Elizabeth I. Buchbinder et al. Journal for ImmunoTherapy of Cancer
- Are topical beta-blockers really effective “in real life” for targeted therapy-induced paronychia
- (2019) Vincent Sibaud et al. SUPPORTIVE CARE IN CANCER
- Increasing the Precision of Hypertension Treatment Through Personalized Trials: a Pilot Study
- (2019) Ian M. Kronish et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- The mystery of metformin
- (2019) Martin J. Spiering JOURNAL OF BIOLOGICAL CHEMISTRY
- Meta-Analysis Comparing Usefulness of Beta Blockers to Preserve Left Ventricular Function During Anthracycline Therapy
- (2019) Priyank Shah et al. AMERICAN JOURNAL OF CARDIOLOGY
- Metformin in breast cancer: preclinical and clinical evidence
- (2019) Anindita De et al. CURRENT PROBLEMS IN CANCER
- The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration
- (2019) Guanqiao Li et al. JOURNAL OF IMMUNOTHERAPY
- Switching to Bortezomib may Improve Recovery From Severe Vincristine Neuropathy in Pediatric Acute Lymphoblastic Leukemia
- (2019) Jaitri Joshi et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Repurposing approved drugs on the pathway to novel therapies
- (2019) Catherine H. Schein MEDICINAL RESEARCH REVIEWS
- Beyond the boundaries of cardiology: Still untapped anticancer properties of the cardiovascular system-related drugs
- (2019) Katarzyna Regulska et al. PHARMACOLOGICAL RESEARCH
- Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma
- (2019) Oscar Arrieta et al. JAMA Oncology
- Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma
- (2019) Shohei Harabuchi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phosphorylation of RAB7 by TBK1/IKKε Regulates Innate Immune Signaling in Triple-Negative Breast Cancer
- (2019) Jessica L. Ritter et al. CANCER RESEARCH
- Effect of beta-blockers on survival of lung cancer patients
- (2019) Marisa Coelho et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations
- (2019) Jennifer Taylor Veneris et al. GYNECOLOGIC ONCOLOGY
- Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
- (2019) Mara Massimi et al. Cells
- Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
- (2019) Simon R. Lord et al. BRITISH JOURNAL OF CANCER
- Regulation of autophagy by canonical and non-canonical ER stress responses
- (2019) Monika Bhardwaj et al. SEMINARS IN CANCER BIOLOGY
- Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy
- (2018) Ines Vasconcelos et al. BREAST
- Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies
- (2018) A. Yap et al. BRITISH JOURNAL OF ANAESTHESIA
- The poor design of clinical trials of statins in oncology may explain their failure – Lessons for drug repurposing
- (2018) Marwan I. Abdullah et al. CANCER TREATMENT REVIEWS
- Infantile hemangiomas
- (2018) Rachael Hagen et al. CURRENT OPINION IN PEDIATRICS
- Topical propranolol for infantile haemangiomas: a systematic review
- (2018) A. Price et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Structural basis of thalidomide enantiomer binding to cereblon
- (2018) Tomoyuki Mori et al. Scientific Reports
- Drug Repositioning for Effective Prostate Cancer Treatment
- (2018) Beste Turanli et al. Frontiers in Physiology
- Meta-analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity
- (2018) Babikir Kheiri et al. AMERICAN JOURNAL OF CARDIOLOGY
- Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
- (2018) Simon R. Lord et al. Cell Metabolism
- Bortezomib ocular toxicities: Outcomes with ketotifen
- (2018) Michael Dennis et al. AMERICAN JOURNAL OF HEMATOLOGY
- Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
- (2018) Joanne M. Jeter et al. CANCER
- Metformin; a review of its history and future: from lilac to longevity
- (2017) Inas Thomas et al. PEDIATRIC DIABETES
- Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase
- (2016) Georg Petzold et al. NATURE
- Fatal gastrointestinal toxicity with ipilimumab after BRAF/ MEK inhibitor combination in a melanoma patient achieving pathological complete response
- (2016) Maria Gonzalez-Cao et al. Oncotarget
- Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells
- (2016) Josep Maria Cornet-Masana et al. Oncotarget
- TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity
- (2016) Alicja Puchta et al. PLoS Pathogens
- Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case Study
- (2015) Andrew J. Krouse et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Circulating TNF and mitochondrial DNA are major determinants of neutrophil phenotype in the advanced-age, frail elderly
- (2015) Chris P. Verschoor et al. MOLECULAR IMMUNOLOGY
- A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
- (2015) Haakon B Nygaard et al. Alzheimers Research & Therapy
- The controversial role of TNF in melanoma
- (2015) Marco Donia et al. OncoImmunology
- A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors
- (2015) Gideon M. Blumenthal et al. Oncotarget
- Membrane Interaction and Functional Plasticity of Inositol Polyphosphate 5-Phosphatases
- (2014) Werner Braun et al. STRUCTURE
- Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine
- (2014) Wilson Wong et al. eLife
- Dexrazoxane for the treatment of chemotherapy-related side effects
- (2014) Seppo Langer Cancer Management and Research
- Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program
- (2014) Roxanne Payne et al. Journal for ImmunoTherapy of Cancer
- Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Alterations of the Intracellular Peptidome in Response to the Proteasome Inhibitor Bortezomib
- (2013) Julia S. Gelman et al. PLoS One
- Comparison of acute toxicity and mortality after two different dosing regimens of high-dose interleukin-2 for patients with metastatic melanoma
- (2013) Laura M. Alwan et al. Targeted Oncology
- Cancer drug discovery by repurposing: teaching new tricks to old dogs
- (2013) Subash C. Gupta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
- (2012) Yuan Xiao Zhu et al. LEUKEMIA & LYMPHOMA
- Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy
- (2012) D J DeAngelo Blood Cancer Journal
- Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
- (2011) B. B. Aggarwal et al. BLOOD
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Anthracycline extravasation injuries: management with dexrazoxane
- (2010) Karin Jordan et al. Therapeutics and Clinical Risk Management
- Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity
- (2008) Dirk M. Maybauer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The prince and the pauper. A tale of anticancer targeted agents
- (2008) Alfonso Dueñas-González et al. Molecular Cancer
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started